Correction: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Seyfrid M, Maich WT, Shaikh VM, et al. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. J Immunother Cancer 2022;10:e003289. doi: 10.1136/jitc-2021-003289.
This article has been corrected since it was first published to correct author name Muhammad Vaseem Shaikh.